ClinicalTrials.gov record
Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)
ClinicalTrials.gov ID: NCT01438775
Public ClinicalTrials.gov record NCT01438775. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
ClinicalTrials.gov public records Last synced May 19, 2026, 11:20 AM EDT
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 3 Multicenter Prospective Open Label Clinical Safety Evaluation of Re-Injection of NX-1207 for the Treatment of BPH: Two Doses 1-7 Years Apart
Study identification
- NCT ID
- NCT01438775
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Nymox Corporation
- Industry
- Enrollment
- 192 participants
Conditions and interventions
Conditions
Interventions
- NX-1207 Drug
Drug
Eligibility (public fields only)
- Age range
- 45 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2011
- Primary completion
- Dec 31, 2012
- Completion
- Dec 31, 2012
- Last update posted
- Apr 29, 2014
2011 – 2013
United States locations
- U.S. sites
- 28
- U.S. states
- 19
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Huntsville | Alabama | 35801 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Atherton | California | 94027 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | San Diego | California | 92103 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Tarzana | California | 91356 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Denver | Colorado | 80211 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Englewood | Colorado | 80113 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | New Britain | Connecticut | 06052 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669 | Sarasota | Florida | 34237 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669 | Meridian | Idaho | 83642 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669 | Forest Hill | Indiana | 47630 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Jeffersonville | Indiana | 47130 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Shreveport | Louisiana | 71106 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669 | Annapolis | Maryland | 21401 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669 | Southaven | Mississippi | 38671 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Missoula | Montana | 59808 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Lawrenceville | New Jersey | 08648 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Albuquerque | New Mexico | 87109 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Brooklyn | New York | 11215 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Garden City | New York | 11530 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | New York | New York | 10016 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Poughkeepsie | New York | 12601 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669 | Concord | North Carolina | 28025 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669 | Bismarck | North Dakota | 58501 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Lancaster | Pennsylvania | 17604 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Memphis | Tennessee | 38119 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Arlington | Texas | 76017 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Houston | Texas | 77024 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669 | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01438775, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 29, 2014 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01438775 live on ClinicalTrials.gov.